Skip to main content
SpringerLink
Log in

Metabolic Disorders

  • Chapter
Dermatological Manifestations of Kidney Disease

  • 1063 Accesses

Abstract

Metabolic disorders including diabetes mellitus, amyloidosis, and atherosclerosis are widespread in our population and, when untreated, can often result in chronic kidney disease. Early diagnosis and treatment therefore are essential. Recognition of dermatologic manifestations of these diseases is becoming increasingly relevant, both for early diagnosis and appropriate treatment of complex disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. About Chronic Kidney Disease. 2013 [cited 2013 April 9th 2013]; Available from: http://www.kidney.org/kidneydisease/aboutckd.cfm

  2. Timshina DK, Thappa DM, Agrawal A. A clinical study of dermatoses in diabetes to establish its markers. Indian J Dermatol. 2012;57(1):20–5.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Levy L, Zeichner JA. Dermatologic manifestation of diabetes. J Diabetes. 2012;4(1):68–76. Epub 2011/08/19.

    Article  PubMed  Google Scholar 

  4. Berlanga-Acosta JS, Schultz G, Lopez-Mola E, Guillen-Nieto G, Garcia-Siverio M, Herrera-Martinez L. Glucose toxic effects on granulation tissue productive cells: the diabetics’ impaired healing. BioMed Res Int. 2013;2013:256043.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Levigne DT, Tobalem M, Modarressi A, Pittet-Cuenod B. Hyperglycemia increases susceptibility to ischemic necrosis. BioMed Res Int. 2013;2013:490964.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Namazi MR, Yosipovitch G. Diabetes mellitus. In: Callen JP, Jorizzo JL, et al., editors. Dermatological signs of internal disease. 4th ed. China: Elsevier Inc.; 2009. p. 189–209.

    Chapter  Google Scholar 

  7. Ferringer T, Miller III F. Cutaneous manifestations of diabetes mellitus. Dermatol Clin. 2002;20(3):483–92.

    Article  PubMed  Google Scholar 

  8. Brugler A, Thompson S, Turner S, Ngo B, Rendell M. Skin blood flow abnormalities in diabetic dermopathy. J Am Acad Dermatol. 2011;65(3):559–63. Epub 2011/05/03.

    Article  PubMed  Google Scholar 

  9. McCash S, Emanuel PO. Defining diabetic dermopathy. J Dermatol. 2011;38(10):988–92. Epub 2011/07/19.

    Article  PubMed  Google Scholar 

  10. Van Hattem S, Bootsma AH, Thio HB. Skin manifestations of diabetes. Cleve Clin J Med. 2008;75(11):772. 4, 6–7 passim. Epub 2008/12/17.

    Article  PubMed  Google Scholar 

  11. Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199–203. Epub 2004/06/10.

    Article  PubMed  Google Scholar 

  12. Santoro N, Amato A, Grandone A, Brienza C, Savarese P, Tartaglione N, et al. Predicting metabolic syndrome in obese children and adolescents: look, measure and ask. Obes Facts. 2013;6(1):48–56. Epub 2013/02/23.

    Article  CAS  PubMed  Google Scholar 

  13. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56(6):901–16. quiz 17–20. Epub 2007/05/17.

    Article  PubMed  Google Scholar 

  14. Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol. 2006;24(4):237–46.

    Article  PubMed  Google Scholar 

  15. Maharshak N, Shapiro J, Trau H. Carotenoderma—a review of the current literature. Int J Dermatol. 2003;42(3):178–81. Epub 2003/03/26.

    Article  PubMed  Google Scholar 

  16. Sehgal VN, Srivastava G, Aggarwal AK, Gupta M, Bhattacharya SN, Verma P. Noninsulin-dependent, type II diabetes mellitus-related dermatoses: part II. Skinmed. 2011;9(5):302–8. Epub 2011/12/15.

    PubMed  Google Scholar 

  17. Apelqvist J. Diagnostics and treatment of the diabetic foot. Endocrine. 2012;41(3):384–97. Epub 2012/03/01.

    Article  CAS  PubMed  Google Scholar 

  18. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28. Epub 2005/01/13.

    Article  CAS  PubMed  Google Scholar 

  19. Bakos RM, Cartell A, Bakos L. Dermatoscopy of early-onset necrobiosis lipoidica. J Am Acad Dermatol. 2012;66(4):e143–4. Epub 2012/03/17.

    Article  PubMed  Google Scholar 

  20. Korber A, Dissemond J. Necrobiosis lipoidica diabeticorum. CMAJ. 2007;177(12):1498. Epub 2007/12/07.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Basarab T, Munn SE, McGrath J, Russell Jones R. Bullosis diabeticorum. A case report and literature review. Clin Exp Dermatol. 1995;20(3):218–20. Epub 1995/05/01.

    Article  CAS  PubMed  Google Scholar 

  22. Lewerenz V, Ruzicka T. Scleredema adultorum associated with type 2 diabetes mellitus: a report of three cases. J Eur Acad Dermatol Venereol. 2007;21(4):560–1. Epub 2007/03/22.

    CAS  PubMed  Google Scholar 

  23. Pitukcheewanont P, Bali B, Somanunt S, Reiff A. Scleroderma-like skin changes not involving the hand in a prepubertal male with type I diabetes mellitus: a case report. Dermatoendocrinol. 2011;3(4):230–2. Epub 2012/01/20.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Yosipovitch G, Loh KC, Hock OB. Medical pearl: scleroderma-like skin changes in patients with diabetes mellitus. J Am Acad Dermatol. 2003;49(1):109–11. Epub 2003/07/02.

    Article  PubMed  Google Scholar 

  25. Saray Y, Seckin D, Bilezikci B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol. 2006;20(6):679–88. Epub 2006/07/14.

    Article  CAS  PubMed  Google Scholar 

  26. Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C. Acquired reactive perforating collagenosis: current status. J Dermatol. 2010;37(7):585–92. Epub 2010/07/16.

    Article  PubMed  Google Scholar 

  27. Roenigk Jr HH, Fowler-Bergfeld W. Eruptive xanthoma. Arch Dermatol. 1969;99(1):125. Epub 1969/01/01.

    Article  PubMed  Google Scholar 

  28. Schreml S, Szeimies RM, Vogt T, Landthaler M, Schroeder J, Babilas P. Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol. 2010;20(2):152–60.

    PubMed  Google Scholar 

  29. Pinney JH, Hawkins PN. Amyloidosis. Ann Clin Biochem. 2012;49(Pt 3):229–41. Epub 2012/03/10.

    Article  CAS  PubMed  Google Scholar 

  30. Gillmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic developments. Br J Haematol. 1997;99(2):245–56.

    Article  CAS  PubMed  Google Scholar 

  31. Fernandez-Flores A. Cutaneous amyloidosis: a concept review. Am J Dermatopathol. 2012;34(1):1–14. quiz 5–7. Epub 2012/01/20.

    Article  PubMed  Google Scholar 

  32. Blancas-Mejia LM, Ramirez-Alvarado M. Systemic amyloidoses. Annu Rev Biochem. 2013;82:745–74. Epub 2013/03/05.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Gillmore JD, Hawkins PN. Drug insight: emerging therapies for amyloidosis. Nat Clin Pract Nephrol. 2006;2(5):263–70.

    Article  CAS  PubMed  Google Scholar 

  34. Piette WW. Dysproteinemias, plasma cell disorders, and amyloidosis. In: Callen JP, Jorizzo JL, et al., editors. Dermatological signs of internal disease. 4th ed. China: Elsevier; 2009.

    Google Scholar 

  35. Wang WJ. Clinical features of cutaneous amyloidoses. Clin Dermatol. 1990;8(2):13–9. Epub 1990/04/01.

    Article  CAS  PubMed  Google Scholar 

  36. Piette WW. Cutaneous manifestations of macrophage/dendritic cell proliferative. In: Callen JP, Jorizzo JL, et al., editors. Dermatological signs of internal disease. 4th ed. China: Elsevier Inc.; 2009. p. 149–60.

    Chapter  Google Scholar 

  37. Wang WJ, Huang JY, Wong CK, Chang YT. A study of secondary cutaneous amyloidosis in basal cell carcinoma in Chinese patients: lack of correlation with bcl-2 or p53 protein expression. Arch Dermatol Res. 2000;292(8):379–83. Epub 2000/09/20.

    Article  CAS  PubMed  Google Scholar 

  38. Chuang YY, Lee DD, Lin CS, Chang YJ, Tanaka M, Chang YT, et al. Characteristic dermoscopic features of primary cutaneous amyloidosis: a study of 35 cases. Br J Dermatol. 2012;167(3):548–54. Epub 2012/05/29.

    Article  CAS  PubMed  Google Scholar 

  39. Lee DY, Kim YJ, Lee JY, Kim MK, Yoon TY. Primary localized cutaneous nodular amyloidosis following local trauma. Ann Dermatol. 2011;23(4):515–8. Epub 2011/12/08.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Borowicz J, Gillespie M, Miller R. Cutaneous amyloidosis. Skinmed. 2011;9(2):96–100. quiz 1. Epub 2011/05/10.

    PubMed  Google Scholar 

  41. Khurana R, Uversky VN, Nielsen L, Fink AL. Is Congo red an amyloid-specific dye? J Biol Chem. 2001;276(25):22715–21. Epub 2001/06/19.

    Article  CAS  PubMed  Google Scholar 

  42. Li WM. Histopathology of primary cutaneous amyloidoses and systemic amyloidosis. Clin Dermatol. 1990;8(2):30–5. Epub 1990/04/01.

    Article  CAS  PubMed  Google Scholar 

  43. Chen W, Dilsizian V. Molecular imaging of amyloidosis: will the heart be the next target after the brain? Curr Cardiol Rep. 2012;14(2):226–33. Epub 2011/12/24.

    Article  PubMed  Google Scholar 

  44. Anitha B, Mysore V. Lichen amyloidosis: novel treatment with fractional ablative 2,940 nm erbium: YAG laser treatment. J Cutan Aesthet Surg. 2012;5(2):141–3. Epub 2012/10/13.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Breathnach SM. The cutaneous amyloidoses. Pathogenesis and therapy. Arch Dermatol. 1985;121(4):470–5. Epub 1985/04/01.

    Article  CAS  PubMed  Google Scholar 

  46. Hernandez-Nunez A, Dauden E, Moreno de Vega MJ, Fraga J, Aragues M, Garcia-Diez A. Widespread biphasic amyloidosis: response to acitretin. Clin Exp Dermatol. 2001;26(3):256–9. Epub 2001/06/26.

    Article  CAS  PubMed  Google Scholar 

  47. Das J, Gogoi RK. Treatment of primary localised cutaneous amyloidosis with cyclophosphamide. Indian J Dermatol Venereol Leprol. 2003;69(2):163–4. Epub 2007/07/24.

    CAS  PubMed  Google Scholar 

  48. Chan HL. Cutaneous manifestations of cardiac diseases. Singapore Med J. 1990;31(5):480–5. Epub 1990/10/01.

    CAS  PubMed  Google Scholar 

  49. Taylor SLG, Greer KE, Jorizzo JL. Lipids. In: Callen JP, Jorizzo JL, et al., editors. Dermatological manifestations of internal disease. 4th ed. China: Elsevier; 2009.

    Google Scholar 

  50. Dwivedi S, Jhamb R. Cutaneous markers of coronary artery disease. World J Cardiol. 2010;2(9):262–9. Epub 2010/12/17.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Becker F, Robert-Ebadi H, Ricco JB, Setacci C, Cao P, de Donato G, et al. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg. 2011;42 Suppl 2:S4–12. Epub 2011/12/30.

    Article  PubMed  Google Scholar 

  52. Pietroleonardo L, Ruzicka T. Skin manifestations in familial heterozygous hypercholesterolemia. Acta Dermatovenerol Alp Panonica Adriat. 2009;18(4):183–7. Epub 2010/01/01.

    Google Scholar 

  53. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM. The pathogenesis of atherosclerosis: an overview. Clin Cardiol. 1991;14(2 Suppl 1):I1–16. Epub 1991/02/01.

    Article  CAS  PubMed  Google Scholar 

  54. Bergman R. Xanthelasma palpebrarum and risk of atherosclerosis. Int J Dermatol. 1998;37(5):343–5. Epub 1998/06/10.

    Article  CAS  PubMed  Google Scholar 

  55. Pandhi D, Gupta P, Singal A, Tondon A, Sharma S, Madhu SV. Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J. 2012;88(1038):198–204. Epub 2012/03/01.

    Article  PubMed  Google Scholar 

  56. Federman DG, Kravetz JD. Peripheral arterial disease: diagnosis, treatment, and systemic implications. Clin Dermatol. 2007;25(1):93–100. Epub 2007/02/06.

    Article  PubMed  Google Scholar 

  57. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608–21. Epub 2001/05/24.

    Article  CAS  PubMed  Google Scholar 

  58. Davis MDP. Leg ulceration. In: Callen JP, Jorizzo JL, et al., editors. Dermatological signs of internal disease. 4th ed. China: Elsevier Inc.; 2009. p. 381–400.

    Chapter  Google Scholar 

  59. Ouriel K. Peripheral arterial disease. Lancet. 2001;358(9289):1257–64. Epub 2001/10/25.

    Article  CAS  PubMed  Google Scholar 

  60. Shai A, Maibach HI. Wound healing and ulcers of the skin: diagnosis and therapy. Berlin: Springer; 2005.

    Google Scholar 

  61. Liem MS, Leuven JA, Bloem JL, Schipper J. Magnetic resonance imaging of Achilles tendon xanthomas in familial hypercholesterolemia. Skeletal Radiol. 1992;21(7):453–7. Epub 1992/01/01.

    Article  CAS  PubMed  Google Scholar 

  62. Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer RH, et al. Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation. 1991;83(2):438–47. Epub 1991/02/01.

    Article  CAS  PubMed  Google Scholar 

  63. Slovut DP, Sullivan TM. Critical limb ischemia: medical and surgical management. Vasc Med. 2008;13(3):281–91. Epub 2008/08/09.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, 5th Floor, New York, NY, 10029, USA

    Davida A. Kornreich M.D.

  2. 240 Central Park S., Apt 7p, New York, NY, 10019, USA

    Davida A. Kornreich M.D.

Authors
  1. Davida A. Kornreich M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Davida A. Kornreich M.D. .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Nelson Clinic, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA

    Julia R. Nunley

  2. Department of Medicine, Section of Nephrology, University of Illinois at Chicago / Advocate Christ Medical Center, Oak Lawn, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kornreich, D.A. (2015). Metabolic Disorders. In: Nunley, J., Lerma, E. (eds) Dermatological Manifestations of Kidney Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2395-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2395-3_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2394-6

  • Online ISBN: 978-1-4939-2395-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation